- €1.53bn
- €1.82bn
- €610.46m
Brief: Faes Farma FY Net Profit At 111.4 Mln Euros
Brief: Faes Farma Gets Laboratory Authorisation For New Manufacturing Plant
Brief: Faes Farma To Pay Interim Dividend Of 0.041 Eur/Shr on Jan 13
Brief: Faes Farma 9-Month Attributable Net Profit At 79.8 Mln Euros
Brief: Faes Farma H1 Net Profit Up At 58.4 Mln Euros YoY
Brief: Faes Farma To Pay Cash Dividend Of 0.116 Eur/Shr On July 8
Spanish stocks - Factors to watch on May 2
Brief: Faes Farma Agrees To Propose Eduardo Recoder As Executive Director
Brief: Faes Farma Q1 Net Profit Up At 30.5 Mln Euros YoY
Brief: Faes Farma Sees 2024 Total Revenues Growth Between 6% And 8%
Brief: Faes Farma FY Net Profit Up At 91.9 Mln Euros YoY
Brief: Faes Farma Approves Payment Of An Interim Cash Dividend Of 0.039 Eur/Shr After 2023 Results
Brief: Faes Farma 9-Month Net Profit Up At 74.2 Mln Euros YoY
Brief: Faes Farma Ends Buy Back Program Acquiring 1.7% Of Share Capital
Brief: Faes Farma H1 Net Profit Slightly Up At 53.0 Mln Euros YoY
Brief: Faes Farma Wins Approval Of Bilastine In China, Termination Of Agreement In US
Brief: Faes Farma Launches Share Buyback For Up To 25.0 Mln Euros
Brief: Faes Farma To Propose Share Capital Reduction Through Redemption Of Up To 5.4 Mln Treasury Shares
Spanish stocks - Factors to watch on May 4